Analysts: Globus Medical Inc (GMED.N)
GMED.N on New York Stock Exchange
16.75USD
1 Aug 2013
16.75USD
1 Aug 2013
Price Change (% chg)
$-0.01 (-0.06%)
$-0.01 (-0.06%)
Prev Close
$16.76
$16.76
Open
$16.82
$16.82
Day's High
$16.88
$16.88
Day's Low
$16.55
$16.55
Volume
78,570
78,570
Avg. Vol
137,319
137,319
52-wk High
$19.90
$19.90
52-wk Low
$10.26
$10.26
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Buy | 0.19 | December | 2 Aug 2013 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 5 | 5 | 5 | 5 |
| (2) OUTPERFORM | 3 | 3 | 3 | 2 |
| (3) HOLD | 0 | 0 | 0 | 0 |
| (4) UNDERPERFORM | 0 | 0 | 0 | 0 |
| (5) SELL | 0 | 0 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 1.38 | 1.38 | 1.38 | 1.29 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 8 | 106.72 | 107.80 | 105.10 | -- |
| Quarter Ending Dec-13 | 8 | 114.75 | 118.40 | 113.35 | -- |
| Year Ending Dec-13 | 8 | 433.96 | 435.70 | 432.40 | -- |
| Year Ending Dec-14 | 8 | 489.07 | 492.28 | 485.79 | -- |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | 6 | 0.19 | 0.20 | 0.19 | -- |
| Quarter Ending Dec-13 | 7 | 0.22 | 0.23 | 0.20 | -- |
| Year Ending Dec-13 | 7 | 0.83 | 0.85 | 0.81 | -- |
| Year Ending Dec-14 | 7 | 0.94 | 0.98 | 0.92 | -- |
| LT Growth Rate (%) | 3 | 15.00 | 18.00 | 13.00 | -- |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Mar-13 | 103.18 | 105.02 | 1.83 | 1.78 |
| Quarter Ending Dec-12 | 99.46 | 100.54 | 1.08 | 1.09 |
| Quarter Ending Sep-12 | 95.32 | 94.76 | 0.56 | 0.58 |
| Earnings (per share) | ||||
| Quarter Ending Mar-13 | 0.20 | 0.21 | 0.01 | 7.14 |
| Quarter Ending Dec-12 | 0.19 | 0.22 | 0.03 | 12.82 |
| Quarter Ending Sep-12 | 0.19 | 0.18 | 0.01 | 6.10 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 106.72 | 106.72 | 106.72 | 106.68 | -- |
| Quarter Ending Dec-13 | 114.75 | 114.75 | 114.75 | 114.68 | -- |
| Year Ending Dec-13 | 433.96 | 433.96 | 433.96 | 433.85 | -- |
| Year Ending Dec-14 | 489.07 | 489.07 | 489.07 | 488.59 | -- |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | 0.19 | 0.19 | 0.20 | 0.20 | -- |
| Quarter Ending Dec-13 | 0.22 | 0.22 | 0.22 | 0.22 | -- |
| Quarter Ending Dec-13 | 0.83 | 0.83 | 0.83 | 0.83 | -- |
| Quarter Ending Dec-14 | 0.94 | 0.94 | 0.94 | 0.93 | -- |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Sep-13 | 0 | 0 | 0 | 0 |
| Quarter Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-14 | 0 | 0 | 0 | 0 |
| Earnings | ||||
| Quarter Ending Sep-13 | 0 | 0 | 0 | 0 |
| Quarter Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-14 | 0 | 0 | 0 | 0 |
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Plunkett Research, Ltd.
|
$99.00
|
|
Provider: Wright Reports
|
$368.00
|
|
Provider: Zacks Investment Research Inc.
|
$12.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Earnings vs.
Estimates